Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,708 | 906 | 98.9% |
| Education | $171.96 | 15 | 1.1% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $2,312 | 116 | $0 (2023) |
| Amgen Inc. | $1,851 | 87 | $0 (2023) |
| PFIZER INC. | $1,599 | 158 | $0 (2023) |
| ABBVIE INC. | $1,556 | 84 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $1,089 | 76 | $0 (2023) |
| UCB, Inc. | $1,014 | 68 | $0 (2023) |
| Lilly USA, LLC | $845.06 | 46 | $0 (2023) |
| Genentech USA, Inc. | $674.07 | 39 | $0 (2023) |
| Mallinckrodt Enterprises LLC | $634.93 | 30 | $0 (2019) |
| GlaxoSmithKline, LLC. | $568.81 | 26 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,547 | 73 | ABBVIE INC. ($224.39) |
| 2022 | $2,705 | 135 | Janssen Biotech, Inc. ($550.46) |
| 2021 | $2,103 | 108 | AbbVie Inc. ($351.65) |
| 2020 | $747.59 | 38 | Horizon Therapeutics plc ($116.25) |
| 2019 | $3,423 | 206 | Amgen Inc. ($429.38) |
| 2018 | $2,700 | 181 | Janssen Biotech, Inc. ($527.21) |
| 2017 | $2,655 | 181 | Novartis Pharmaceuticals Corporation ($343.79) |
All Payment Transactions
922 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/31/2023 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $16.31 | General |
| Category: Immunology | ||||||
| 06/29/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: IMMUNOLOGY | ||||||
| 06/28/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: RESPIRATORY | ||||||
| 06/28/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $3.30 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 06/26/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Immunology | ||||||
| 06/22/2023 | Genentech USA, Inc. | Actemra (Biological), Rituxan | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: Immunology | ||||||
| 06/22/2023 | PFIZER INC. | XELJANZ (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $5.12 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 06/21/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: IMMUNOLOGY | ||||||
| 06/16/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: KRYSTEXXA | ||||||
| 06/14/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $31.20 | General |
| Category: Immunology | ||||||
| 06/12/2023 | Amgen Inc. | Enbrel (Biological), TAVNEOS | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: Inflammation | ||||||
| 06/08/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Immunology | ||||||
| 06/07/2023 | PFIZER INC. | XELJANZ (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 06/07/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $16.88 | General |
| Category: Not Applicable | ||||||
| 06/04/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: IMMUNOLOGY | ||||||
| 05/31/2023 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Immunology | ||||||
| 05/25/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $18.43 | General |
| Category: Not Applicable | ||||||
| 05/22/2023 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 05/16/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: Immunology | ||||||
| 05/11/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $31.49 | General |
| Category: Immunology | ||||||
| 05/10/2023 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: Inflammation | ||||||
| 05/10/2023 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Endocrinology | ||||||
| 05/09/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/04/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Immunology | ||||||
| 05/03/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,299 | 22,949 | $871,131 | $372,291 |
| 2022 | 24 | 1,847 | 57,455 | $2.5M | $1.1M |
| 2021 | 24 | 1,994 | 29,565 | $1.8M | $897,383 |
| 2020 | 24 | 1,769 | 15,485 | $720,956 | $366,634 |
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 85 | 5,640 | $170,040 | $101,073 | 59.4% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 27 | 2,950 | $206,500 | $99,534 | 48.2% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 16 | 3,950 | $197,500 | $42,785 | 21.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 257 | 420 | $73,500 | $41,994 | 57.1% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 11 | 8,600 | $60,200 | $39,769 | 66.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 75 | 109 | $58,025 | $13,058 | 22.5% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 92 | 155 | $38,750 | $10,850 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 92 | $11,500 | $6,411 | 55.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $13,680 | $4,868 | 35.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 21 | 50 | $10,535 | $4,119 | 39.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 252 | 344 | $5,848 | $2,890 | 49.4% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 15 | 57 | $8,550 | $1,530 | 17.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 11 | 11 | $1,925 | $679.80 | 35.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 76 | 86 | $2,580 | $654.46 | 25.4% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 13 | 13 | $4,225 | $592.54 | 14.0% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 12 | 14 | $1,120 | $497.98 | 44.5% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2023 | 81 | 94 | $1,410 | $392.92 | 27.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 26 | $1,300 | $327.75 | 25.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 27 | 173 | $432.50 | $142.50 | 32.9% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 13 | 15 | $150.00 | $66.57 | 44.4% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 75 | 112 | $3,360 | $55.41 | 1.6% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 52 | 9,026 | $631,820 | $312,974 | 49.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 82 | 8,280 | $212,220 | $142,100 | 67.0% |
| J0490 | Injection, belimumab, 10 mg | Office | 2022 | 17 | 3,302 | $264,160 | $127,498 | 48.3% |
| J9312 | Injection, rituximab, 10 mg | Office | 2022 | 13 | 1,600 | $176,600 | $107,527 | 60.9% |
About Dr. Sara Johnson, M.D
Dr. Sara Johnson, M.D is a Rheumatology healthcare provider based in Smithtown, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1043206964.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sara Johnson, M.D has received a total of $15,880 in payments from pharmaceutical and medical device companies, with $1,547 received in 2023. These payments were reported across 922 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($15,708).
As a Medicare-enrolled provider, Johnson has provided services to 6,909 Medicare beneficiaries, totaling 125,454 services with total Medicare billing of $2.7M. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location Smithtown, NY
- Active Since 09/26/2005
- Last Updated 05/19/2014
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1043206964
Products in Payments
- XELJANZ (Drug) $1,425
- Enbrel (Biological) $1,138
- COSENTYX (Biological) $1,020
- Cimzia (Drug) $1,014
- SIMPONI ARIA (Biological) $855.78
- RINVOQ (Biological) $758.13
- ACTHAR (Biological) $717.65
- TALTZ (Drug) $655.48
- BENLYSTA (Biological) $568.81
- Humira (Biological) $544.81
- TREMFYA (Drug) $504.26
- REMICADE (Biological) $491.89
- EVENITY (Biological) $417.82
- Rituxan (Biological) $386.31
- KRYSTEXXA (Biological) $377.71
- STELARA (Biological) $352.54
- SAPHNELO (Biological) $348.01
- KEVZARA (Biological) $322.67
- Tymlos (Biological) $320.84
- Actemra (Biological) $287.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Smithtown
Paul Schulman, M.d, M.D
Rheumatology — Payments: $79,855
Howard Blumstein, M.d, M.D
Rheumatology — Payments: $59,211
Hong Xu, M.d, M.D
Rheumatology — Payments: $49,108
Luiziana Marinescu, M.d, M.D
Rheumatology — Payments: $32,828
Mr. Mark Tan, M.d, M.D
Rheumatology — Payments: $21,914
Peter Rumore, M.d, M.D
Rheumatology — Payments: $17,575